Investlytic Investlytic
Log in Free Account
English
🕒 Last update: loading…

Stock Emeis EMEIS.PA

Emeis — Investlytic score 1/5 on the five criteria.

-
-
0/ 100
Score Investlytic · 5 criteria

Analysis in progress…

Investlytic score: 1/5 criteria met. Data as of 17/09/2026.

  • ❌ Price trend failed
  • ⚠️ Mixed growth
  • ❌ Debt failed
  • ❌ P/E failed
  • ✅ Correction passed

Price trend

Overall trend (8 years): insufficient progression (less than x1.5).

Price change 2018 → 2019: 28.11%

Price change 2019 → 2020: -5.91%

Price change 2020 → 2021: -18.08%

Price change 2021 → 2022: -92.99%

Price change 2022 → 2023: -95.74%

Price change 2023 → 2024: -63.91%

Price change 2024 → 2025: 136.47%

Price change 2025 → 2026: -11.03%

Price change 2026 (year to date): -12.79%

Financial growth

Revenue CAGR (8 years): 8.09%

Earnings CAGR (8 years): N/A

Growth status: positive trend (>1%/yr) in revenue, earnings data insufficient/N/A.

Debt

Debt-to-equity ratio: 6.11

Debt/equity > 0.5 (maximum threshold).

P/E (Price/Earnings)

P/E ratio: -8.00

P/E > 25.0 (maximum threshold).

Correction (6 months)

Current correction: 16.83% from the high over 6 months.

Correction between 10.0% and 20.0% (target range).

WATCH
The stock is currently being evaluated.

Criteria of the Investlytic model

- / 5
🔒

Investlytic rating reserved for members

Score out of 100, model verdict (buy, watch, sell) and details of the 5 criteria · visible with a free account.

Create a free account Log in
02

Price trend

Price & trend

Interactive chart →
Loading chart…

⚖️ Comparison with the market

All stocks →
StockP/EDette/FPRevenue growthRating
Emeis–6.11+11.4 %🔒
Clariane SE565.52.16+12.4 %–
Lumibird S.A.37.30.71+9.8 %–
Valneva SE–1.95+22.4 %–
bioMérieux S.A.22.50.11+7.6 %–

Data from the Investlytic screener. The rating of the stock being viewed is reserved for members.

03

Detailed analysis · Price trend

-

🔒

Reserved for members

Global model trend and annual price variations · visible with a free account.

Create a free account Log in
04

Revenues & profits

Revenue and net income

🔒

Reserved for members

Chart of revenues and net income over 8 periods · real data, no estimates.

Create a free account Log in
05

Financial indicators

🔒

Reserved for members

18 financial indicators analyzed by groups of criteria: valuation, profitability, growth, solidity, dividend, and momentum.

Create a free account Log in
06

Annual financial statements

Fiscal yearRevenueNet income Net marginEPSRevenue growth
🔒

Reserved for members

Complete annual financial statements: revenue, net income, margin, and EPS over 8 fiscal years.

Create a free account Log in
07

Similar stocks